It is typically administered as a simple, once-weekly injection
Feeling excessively hot or sweating more than usual
Upcoming patent expiries (Semaglutide wave ) Massive demand for obesity & diabetes solutions Indias strength in affordable generics The Opportunity Multi-billion dollar market Potential global supply hub Rapid adoption beyond diabetes But heres the real shift: Were moving from treatment metabolic health management The companies that win wont just manufacture theyll innovate, scale, and make these therapies accessible
Not approved for human consumption, veterinary use, or clinical application.
Their product pages talked about weight loss and appetite, and they sold injection water right next to the peptides
The FDA approval is for patients at a BMI of 30 or above, or in some cases between 27 and 30, if they have significant comorbid conditions," O'Neil said